Floatz logo

Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta And Tyrosinase Related Protein 1

Metastatic Mucosal Melanoma

Mayo Clinicgene_therapyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Metastatic Mucosal Melanoma cohort.

Asset / SponsorPhaseRating
INTERFERON ALFA-2B
Shanghai Junshi Bioscience Co., Ltd.
Phase 3B
Encorafenib
SWOG Cancer Research Network
Phase 2CCC
Binimetinib
SWOG Cancer Research Network
Phase 2CCC
Tyrosinase-Related Protein-1
Mayo Clinic
Phase 1CC
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Mayo Clinic
Phase 1CC

Same molecule, other indications

Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta And Tyrosinase Related Protein 1 is also rated in:

Metastatic Choroid MelanomaDormant
CC
Indicative ·
43 / 100
View asset →
Unresectable MelanomaDormant
CC
Indicative ·
43 / 100
View asset →
Clinical Stage III Cutaneous Melanoma AJCC v8Dormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →